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Background and objectives.— Restrictive valvular heart disease has
recently been reported in patients after benﬂuorex exposure. How-
ever, little is known about its prevalence and echocardiographic
features. The aim of our study was to assess the prevalence of ben-
ﬂuorex exposure in patients with restrictive mitral or aortic valve
disease and to describe their echocardiographic characteristics.
Methods.— In a single center study, patients with a ﬁnal diagnosis of
unexplained restrictive aortic and/or mitral valvular disease were
studied. Only patients with at least moderate valvular regurgita-
tion were included. All echocardiographic records were analysed
by two experienced observers. Patients were interrogated for their
previous use of benﬂuorex or other appetit-suppressant drugs.
Results.— Sixty-eight consecutive patients, aged 58± 9 years, with
restrictive aortic and/or mitral valvular disease were studied,
including 63 (93%) women. Among them, 54 (82%) had had previ-
ous treatment with appetit-suppressant drugs, including benﬂuorex
alone in 19 (28%) patients, or in combination with another appetit-
suppressant drug, mainly dexfenﬂuramine, in the remaining cases.
Among patients with both mitral and aortic involvement, 39 (97%)
had been exposed to benﬂuorex, isolated (n = 14) or in combination
with another appetit-suppressant drug (n = 25). Echocardiographic
features included combined mitral and aortic regurgitation with
restricted valve motion in 40 (59%) cases, and isolated mitral or
aortic involvement in 5 and 12 patients, respectively.
Conclusion.— The prevalence of appetit-suppressant drugs expo-
sure is very high in patients with left heart restrictive valvular
regurgitation. Multiple drugs exposure is frequent in these patients.
Combined aortic and mitral restrictive valve regurgitation is highly
suggestive of valvulopathy associated with benﬂuorex or other
appetit-suppressant drug valve disease.
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valuation of right ventricular function in patients with organic
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bjectives.— The aim of this study was to assess right ventricular
RV) ejection fraction (EF) and its determinants in patients with
rganic mitral regurgitation (MR) by radionuclide angiography.
ethods.— Two-hundred eight patients (62± 13 years, 135 males)
ith moderate to severe organic MR underwent an echocardio-
raphic examination and left and right ventricular assessment by
adionuclide angiography. The left ventricle (LV) was divided into 9
egions to assess regional LV function.
esults.— Mean RV EF was 40± 10%, ranging from 10 to 65%.
ne hundred ﬁfty-one patients were in sinus rhythm, and 57
atients (27%) in atrial ﬁbrillation. Tricuspid annulus S wave
elocity measured in a subset of patients (n = 92) correlated
eakly with RV EF (r = 0.27, P = 0.018). Fifty-nine patients (28%)
ad a RV EF < 35%. Patients with RV EF < 35% had lower systolic
lood pressure (P = 0.045), larger RV (P = 0.007), higher pulmonary
rtery systolic pressure (PASP, P = 0.045) and had more diuretics
P = 0.009) compared with those with RV EF > 35%. In univariate
nalysis, echocardiographic predictors of RVEF were LVEF (r = 0.33,
< 0.0001), LV end-diastolic diameter (r =−0.26, P = 0.001) and vol-
me (r =−0.29, P = 0.001), left atrial size (r =−0.22, P = 0.003),
itral E velocity (r =−0.29, P < 0.0001), PASP (r =−0.22, P = 0.004),
nd aortic stroke volume (r = 0.31, P = 0.007). In the subset of
atients with effective regurgitant oriﬁce (ERO) and regurgitant vol-
me quantiﬁcation RV EF correlated with ERO (r =−0.34, P = 0.005)
nd regurgitant volume (r =−0.33, P = 0.008). RV EF correlated
losely with radionuclide LV septal function (regional LV EF 8:
= 0.49, P < 0.0001). In multivariate analysis, LV septal function
r = 0.43, P < 0.0001) was the main determinant of RV function. LV
nd-diastolic diameter (r =−0.25, P < 0.0001) and PASP (r =−0.18,
= 0.009) were also independent predictors of RVEF.
